Review
doi: 10.1111/j.1751-1097.2011.00986.x.
Epub 2011 Sep 19.
Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer
Affiliations
- PMID: 21848905
- DOI: 10.1111/j.1751-1097.2011.00986.x
Item in Clipboard
Review
Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer
Photochem Photobiol.
2011 Nov-Dec.
Abstract
This review traces the development and study of the second-generation photosensitizer 5,10,15,20-tetra(m-hydroxyphenyl)chlorin through to its acceptance and clinical use in modern photodynamic (cancer) therapy. The literature has been covered up to early 2011.
© 2011 The Authors. Photochemistry and Photobiology © 2011 The American Society of Photobiology.
Similar articles
-
The Photosensitizer Temoporfin (mTHPC) - Chemical, Pre-clinical and Clinical Developments in the Last Decade.Photochem Photobiol. 2023 Mar;99(2):356-419. doi: 10.1111/php.13730. Epub 2022 Nov 3. Photochem Photobiol. 2023. PMID: 36161310 Review.
-
mTHPC--a drug on its way from second to third generation photosensitizer?Photodiagnosis Photodyn Ther. 2012 Jun;9(2):170-9. doi: 10.1016/j.pdpdt.2011.10.001. Epub 2011 Nov 1. Photodiagnosis Photodyn Ther. 2012. PMID: 22594988 Review.
-
Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):709-11. doi: 10.1001/archotol.129.7.709. Arch Otolaryngol Head Neck Surg. 2003. PMID: 12874068 Clinical Trial.
-
Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.Br J Cancer. 1999 Oct;81(4):600-8. doi: 10.1038/sj.bjc.6690736. Br J Cancer. 1999. PMID: 10574244 Free PMC article.
-
Chemical modification of temoporfin--a second generation photosensitizer activated using upconverting nanoparticles for singlet oxygen generation.Chem Commun (Camb). 2014 Oct 18;50(81):12150-3. doi: 10.1039/c4cc05867d. Chem Commun (Camb). 2014. PMID: 25174720
Cited by
-
The Use of Photoactive Polymeric Nanoparticles and Nanofibers to Generate a Photodynamic-Mediated Antimicrobial Effect, with a Special Emphasis on Chronic Wounds.Pharmaceutics. 2024 Feb 5;16(2):229. doi: 10.3390/pharmaceutics16020229. Pharmaceutics. 2024. PMID: 38399283 Free PMC article. Review.
-
Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo.Pharmaceutics. 2023 Nov 28;15(12):2694. doi: 10.3390/pharmaceutics15122694. Pharmaceutics. 2023. PMID: 38140035 Free PMC article.
-
Antitumor Immunity Mediated by Photodynamic Therapy Using Injectable Chitosan Hydrogels for Intratumoral and Sustained Drug Delivery.Biomacromolecules. 2024 Jan 8;25(1):24-42. doi: 10.1021/acs.biomac.3c00591. Epub 2023 Oct 27. Biomacromolecules. 2024. PMID: 37890872
-
Photosensitizers for Photodynamic Therapy of Brain Cancers-A Review.Brain Sci. 2023 Sep 8;13(9):1299. doi: 10.3390/brainsci13091299. Brain Sci. 2023. PMID: 37759900 Free PMC article. Review.
-
Trial watch: an update of clinical advances in photodynamic therapy and its immunoadjuvant properties for cancer treatment.Oncoimmunology. 2023 Jun 18;12(1):2226535. doi: 10.1080/2162402X.2023.2226535. eCollection 2023. Oncoimmunology. 2023. PMID: 37346450 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
